Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články, multicentrická studie
PubMed
31782043
DOI
10.1007/s11239-019-02000-x
PII: 10.1007/s11239-019-02000-x
Knihovny.cz E-zdroje
- Klíčová slova
- Atrial fibrillation, Awareness, Early detection of disease, Pharmacists, Pulse check,
- MeSH
- časná diagnóza MeSH
- dospělí MeSH
- farmaceuti * MeSH
- fibrilace síní diagnóza MeSH
- internacionalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- průřezové studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- zdraví - znalosti, postoje, praxe MeSH
- zdravotní výchova metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Atrial fibrillation (AF) accounts for up to one third of strokes, one of the lead mortality causes worldwide. The European Society of Cardiology guidelines recommend opportunistic screening as a means to increase the odds of early detection and institution of appropriate treatment according to risk factors identified. However, in most countries there are various barriers to effective uptake of screening, including low awareness. The Atrial Fibrillation Association is a patient association engaged with raising awareness of AF. Establishing a partnership with the International Pharmacists for Anticoagulation Care Taskforce, we set as goals to test a model for raising awareness of AF involving pharmacists globally; and to identify barriers and enablers to its implementation. A cross-sectional study was conducted during the Arrhythmia Alliance World Heart Rhythm Week. Pharmacists from 10 countries invited individuals (≥ 40 years; without anticoagulation therapy of AF) to participate in the awareness campaign. Participants agreeing were engaged in the early detection of AF (EDAF) using pulse palpation. Individuals with rhythm discrepancies were referred and prospectively assessed to have information on the proportion of confirmed diagnosis, leading to estimate the detection rate. Interviews with country coordinators explored barriers and enablers to implementation. The study involved 4193 participants in the awareness campaign and 2762 in the EDAF event (mean age 65.3 ± 13.0), of whom 46.2% individuals were asymptomatic, recruited across 120 sites. Most common CHA2DS2-VASc risk factor was hypertension. Among 161 patients referred to physician, feedback was obtained for 32 cases, of whom 12 new arrhythmia diagnoses were confirmed (5 for AF, 2 for atrial flutter), all among elders (≥ 65 years). Qualitative evaluation suggested a local champion to enable pharmacists' success; technology enhanced engagement amongst patients and increased pharmacists' confidence in referring to physicians; interprofessional relationship was crucial in success. This study suggests pharmacists can contribute to greater outreach of awareness campaigns. Effective communication pathways for inter-professional collaboration were suggested enablers to gain full benefits of EDAF.
Barts Health NHS Trust UCL Partners 9 Prescot Street Aldgate London E1 8PR UK
Centre for Learning Enhancement and Research The Chinese University of Hong Kong Shatin Hong Kong
Faculdade de Farmácia The Research Institute for Medicines Universidade de Lisboa Lisbon Portugal
Faculty of Pharmacy University of Szeged Zrínyi u 9 Szeged 6720 Hungary
Farmácia Nuno Álvares Avenida D Nuno Álvares Pereira 39 C Almada Portugal
Leslie Dan Faculty of Pharmacy University of Toronto 144 College St Toronto ON M5S 3M2 Canada
Westview Pharmacy 5 Glendale Road Glen Eden Auckland 0602 New Zealand
Zobrazit více v PubMed
Nurse Res. 2006 Jul 1;13(4):84 PubMed
Int J Pharm Pract. 2014 Dec;22(6):397-406 PubMed
Circulation. 2015 Jun 23;131(25):2176-84 PubMed
Int J Clin Pharm. 2016 Aug;38(4):784-7 PubMed
Prim Care Diabetes. 2010 Oct;4(3):155-64 PubMed
Eur Heart J. 2016 Oct 7;37(38):2893-2962 PubMed
Int J Cardiol. 2013 Apr 15;164(3):371-2 PubMed
Aust Fam Physician. 2014 May;43(5):315-9 PubMed
Europace. 2017 Oct 1;19(10):1589-1623 PubMed
Acta Cardiol. 2012 Jun;67(3):273-8 PubMed
Eur Heart J. 2006 Apr;27(8):949-53 PubMed
Diabet Med. 2011 Aug;28(8):987-93 PubMed
CMAJ Open. 2017 Aug 22;5(3):E653-E661 PubMed
Aust N Z J Public Health. 2007 Dec;31(6):516-9 PubMed
Int J Clin Pharm. 2017 Dec;39(6):1282-1290 PubMed
Pharm World Sci. 2010 Jun;32(3):373-80 PubMed
Thromb Haemost. 2014 Jun;111(6):1167-76 PubMed
Int J Clin Pharm. 2015 Dec;37(6):1111-20 PubMed
Circulation. 2017 May 9;135(19):1851-1867 PubMed
J Fam Pract. 2006 Feb;55(2):130-4 PubMed
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74 PubMed
Circulation. 2017 Nov 7;136(19):1784-1794 PubMed
Open Heart. 2016 Dec 23;3(2):e000515 PubMed
Can Med Assoc J. 1964 Sep 12;91(11):619 PubMed
Thromb Haemost. 2013 Aug;110(2):213-22 PubMed